Immunomodulation by thalidomide and thalidomide analogues
Open Access
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 58 (suppl 1) , I107-I113
- https://doi.org/10.1136/ard.58.2008.i107
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Thalidomide Stimulates T Cell Responses and Interleukin 12 Production in HIV-Infected PatientsAIDS Research and Human Retroviruses, 1999
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisPublished by Elsevier ,1999
- Thalidomide in Crohn's diseaseThe Lancet, 1997
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- ThalidomideDrug Safety, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Cytokine mediators of septic infections in the normal and granulocytopenic hostEuropean Journal of Haematology, 1993
- Thalidomide in Human Immunodeficiency Virus (HIV) PatientsDrug Safety, 1992
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989